|Podcasts|October 28, 2022

Insights on Insight Gathering

Author(s)Julian Upton

Understanding markets, influencers, and patients through better stakeholder engagement and faster analysis

Lance Hill, CEO of insights management company Within3, talks about how the insights gathering process supports better drug discovery and more representative outcomes, and how data can democratize healthcare and mitigate DE&I in the industry.

The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.


Related to this article

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | © Tada Images - stock.adobe.com 521699065
In this week’s Pharma Pulse, the FDA launches a program that lets companies share its approval packages with foreign regulators, UPS agrees to acquire Australia and New Zealand health care courier Smartways Logistics and Cognizant introduces an AI-enabled patient hub offering.
CVS Pharmacy Sign at Storefront Entrance | © Mark Roger Bailey - stock.adobe.com 557616813
In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean for its launch strategies and an ACTO survey finds most life sciences leaders see no clear industry standard for responsible AI.